ARCTURUS THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 16 Feb 2024)
What this means for you
Registered since 10 Apr 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86563776
- Registration number
- 5443638
- Mark type
- Stylized text
- Filed
- 13 Mar 2015
- Published for opposition
- 19 Jan 2016
- Registered
- 10 Apr 2018
- Attorney of record
- Kevin M. Bovard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome
- Class 042 — Scientific and technological services: Scientific and medical research
Owner
- Arcturus Therapeutics, Inc., San Diego, CA, US
- Arcturus Therapeutics, Inc., San Diego, CA, US
- Arcturus Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 16 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 10 Apr 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Apr 2018 — REGISTERED-PRINCIPAL REGISTER
- 08 Mar 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Mar 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Mar 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Feb 2018 — USE AMENDMENT FILED
- 28 Feb 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2018 — TEAS STATEMENT OF USE RECEIVED
- 02 Sept 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Aug 2017 — SOU EXTENSION 3 GRANTED
- 31 Aug 2017 — SOU EXTENSION 3 FILED